1 / 15

Threauptics- 1minor case presentationtation type 2 DM with asthma

Threauptics- 1minor case presentationtation type 2 DM with asthma. By. Patient name : irappa bassapa Age : 67 male Chief complaints cough with expectoration since 20 days fever since 20 days. SENARIO. Past medical history DM – 2 Hypertension 8 – 10 years

galbreath
Download Presentation

Threauptics- 1minor case presentationtation type 2 DM with asthma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Threauptics- 1minor case presentationtationtype 2 DM with asthma By.

  2. Patient name : irappa bassapa • Age : 67 male • Chief complaints • cough with expectoration since 20 days • fever since 20 days SENARIO

  3. Past medical history • DM – 2 • Hypertension 8 – 10 years • Past medication history • T.glycomet fort gp • T.ramise fort 25mg OD

  4. Lab data

  5. SUBJECTIVE : here is the patient with 67y male subjected with cough with expectoration since 20 days and fever since 20 days. SOAP

  6. OBJECTIVE SPUTUM : GRAM NEGATIVE BACILLI IS SEEN.

  7. Problem 1 :cough It occurs due to the presence of any exogenous substances and a endogenous stimuli where it expels the obstruction causing substances from respiratory tract problem 2 : fever Its occurs due to the presence of pyrogens which are the toxic substances released from the disease causing organisms Assessment

  8. problem 3 : type 2 DM It occurs due to the insulin resistance to the tissue and poor intake of glucose by skeletal muscles. Problem 4 :asthma Its a type 1 hypersensitivity reaction which is characterised by reversible airflow obstruction and bronchospasm.

  9. Threauptic plan

  10. TYPE 2 DM: T. Glycomet :metformin 500 mg It acts by decreasing the hepatic glucose production and peripheral insulin sensitivity. Bronchial asthma. Inj.deriphyline Acts by Inhibiting of phosphodiasterace and antagonism of adenosine receptors,therby causing bronchodilation. Plan

  11. Syr.bruzedex :bromohexene hcl it act as an expectorant/mucolytic agent which expels out the mucus secreated. In.cefra :ceftrixone it exhibits bactericidal activity by the inhibition of bacterial wall synthesis by binding with cephalosporin binding proteins.

  12. T.akurit 4:[ isoniazid ,rifampicin,pyrazemide,etambutanol ] • : Isoniazid :it acts by inhibition of mycolic acid synthesis and disruption of the cell wall in susceptible organism : Rifampin: a semisynthetic broad-spectrum bactericidal antibiotic, inhibits bacterial RNA synthesis by binding strongly to the beta subunit of DNA-dependent RNA polymerase, preventing attachment of the enzyme to DNA, and thus blocking initiation of RNA transcription [2 • Ethambutol :. It inhibits the synthesis of certain metabolites subsequently impairing cell metabolism leading to cell death.

  13. t.zorfer :ondancetron • . Ondansetron may work by blocking 5-HT3 receptors peripherally on vagal nerve terminals and centrally in the chemoreceptor trigger zone . • Inj.rablet : rabeperazole • Rabeprazole sodium is a gastric proton pump inhibitor . It suppresses gastric acid secretion by inhibiting the gastric H+, K+-ATPase at the secretory surface of parietal cells [10] others

  14. Theophylline + rifampicin: moderate Theophyline reduce it effects by riampicin. Frequency should be changed. Discharged drugs T .akurit 2-0-0 for 90 days T.Ecospirin 101 foe60 days Cap.beneficale 0-1-0 for 30 days t.Forte b 0-1-0 for 15 days t.Glycomet 1-0-0 for 30 days. Drug interactions

More Related